| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TTC3_0018000 | Exon-Exon | chr21:38505037-38512973 | chr21:37132737-37140673 | 359 nt | 0.4150 |
| hsa_TTC3_0018100 | Exon-Exon | chr21:38507680-38516945 | chr21:37135380-37144645 | 450 nt | 0.4044 |
| hsa_TTC3_0018300 | Exon-Exon | chr21:38507680-38519903 | chr21:37135380-37147603 | 135 nt | 0.4148 |
| hsa_TTC3_0018400 | Exon-Exon | chr21:38507680-38525577 | chr21:37135380-37153277 | 135 nt | 0.4148 |
| hsa_TTC3_0018200 | Exon-Exon | chr21:38507680-38536517 | chr21:37135380-37164215 | 1892 nt | 0.3827 |
| hsa_TTC3_0018500 | Exon-Exon | chr21:38510934-38512973 | chr21:37138634-37140673 | 194 nt | 0.4124 |
| hsa_TTC3_0018600 | Intron-Exon-Intron | chr21:38510934-38513592 | chr21:37138634-37141292 | 813 nt | 0.3333 |
| hsa_TTC3_0018800 | Exon-Exon | chr21:38510934-38516945 | chr21:37138634-37144645 | 81 nt | 0.4444 |
| hsa_TTC3_0018900 | Exon-Exon | chr21:38510934-38519903 | chr21:37138634-37147603 | 81 nt | 0.4444 |
| hsa_TTC3_0019000 | Exon-Exon | chr21:38510934-38522470 | chr21:37138634-37150170 | 81 nt | 0.4444 |
A study in humans demonstrated that the circTTC3 shows a significant decrease in the peripheral blood of Alzheimer's disease patients, suggesting its potential to distinguish this condition from other dementias [Misir et al. DOI:10.1038/s41418-022-00948-7]. In mice and rats, circTTC3 was markedly upregulated in ischemic myocardium post-myocardial infarction and counteracted hypoxia-induced ATP depletion and apoptotic death in cardiomyocytes via the miR-15b/Arl2 axis [Tian et al. DOI:10.3390/molecules26041155]. It also alleviated hypoxic injury in HaCaT cells via miR-449a/NF-κB and PI3K/AKT pathways [Huang et al. DOI:10.3390/cells11091381].